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Both inflammatory and haemodynamic factors have been
implicated in the pathogenesis of diabetic and other
progressive glomerulopathies. Mesangial cell exposure to
mechanical stretch induces both intercellular adhesion
molecule 1 (ICAM-1) and monocyte chemoattractant
protein-1 (MCP-1) expression. CC Chemokine receptor 2
(CCR2), the cognate MCP-1 receptor, has been recently
demonstrated in human mesangial cells (HMCs). We tested
whether MCP-1 binding to CCR2 affects ICAM-1 expression in
HMCs and, secondly, if stretch-induced ICAM-1 is mediated
by MCP-1 via an autocrine mechanism. Serum-deprived HMCs
were exposed to either rh-MCP-1 (0.1–1–10–50–100 ng/ml)
or mechanical stretch in the presence and in the absence
of RS102895, a specific CCR2 inhibitor. ICAM-1 expression
was assessed both by immunofluorescence and
cytofluorimetry. Monocyte–HMC interaction was tested by
adhesion assay. CCR2 expression was studied by reverse
transcriptase-polymerase chain reaction, immunoblotting,
and flow cytometry. HMCs exposure to rh-MCP-1 induced a
significant twofold increase in ICAM-1 expression at 24 h,
leading to enhanced monocyte adhesion. This effect occurred
via the CCR2 receptor as CCR2 was expressed in HMCs
and CCR2 blockade prevented ICAM-1 upregulation.
Stretch-induced ICAM-1 expression was not altered by CCR2
blockade and stretch significantly reduced CCR2 mRNA and
protein expression via an MCP-1-independent mechanism. In
conclusion, stretch and MCP-1 independently induce ICAM-1
expression in HMCs. Stretch-induced CCR2 downregulation
may favour MCP-1 paracrine activity.
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Both hyperglycaemia and glomerular capillary hypertension
are important in the pathogenesis of diabetic kidney
disease.1,2 Furthermore, there is evidence of a contribution
of inflammatory mechanisms in the pathogenesis of the
glomerular damage in diabetes. Glomerular infiltration of
macrophages has been histologically demonstrated in renal
biopsies from patients with diabetic nephropathy.3 Monocyte
chemoattractant protein-1 (MCP-1), a monocyte chemokine,
and intercellular adhesion molecule-1 (ICAM-1), a trans-
membrane glycoprotein enabling binding to monocytes, are
overexpressed in the glomeruli from diabetic animals.4–6
There is amelioration of both proteinuria and glomerular
histological damage in ICAM-1 knockout diabetic mice7 and
strategies lowering glomerular MCP-1 expression have
renoprotective effects in experimental diabetes.5,8
CC chemokine receptor 2 (CCR2) is the cognate MCP-1
receptor and mediates the recruitment of circulating mono-
cytes.9 CCR2 is predominantly expressed on monocytes, but
a functionally active CCR2 receptor has also been demon-
strated in other cell types, such as vascular smooth muscle
cells,10 endothelial cells,11 and fibroblasts.12 In addition, in
CCR2 knockout mice there is a profound reduction in
intimal hyperplasia after arterial injury despite no difference
in monocyte accumulation in the arterial wall, suggesting
that in vivo the MCP-1/CCR2 system has activities that
extend beyond monocyte recruitment.13,14
Recent studies have shown that cultured mesangial cells
can express CCR2.15,16 However, it is unknown whether in
mesangial cells the CCR2 receptor is functionally active and
can mediate, at least in part, the inflammatory response
induced by MCP-1. Glomerular macrophage infiltration
requires not only monocyte migration in response to a
chemokine gradient, but also monocyte interaction with
resident renal cells. ICAM-1 is the most important adhesion
molecule in this process17,18 and it is thus a potential target of
MCP-1 action.
Infiltrating monocytes are the predominant source of
MCP-1 in the glomeruli; however, resident glomerular cells
also produce MCP-1 and we have recently reported that stret-
ching of mesangial cells, mimicking the haemodynamic insult
of glomerular capillary hypertension in vivo, enhances MCP-1
expression.19 This suggests that MCP-1 may also act on
mesangial cells via an autocrine mechanism. Stretch-induced
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ICAM-1 expression has been reported in mesangial
cells,20 but the role of the MCP-1/CCR2 system in this
remains to be established.
The present study was designed to test whether the MCP-
1/CCR2 system has direct proinflammatory effects in human
mesangial cells (HMCs). Specifically, we investigated whether
MCP-1 binding to CCR2 induces ICAM-1 expression,
leading to monocyte adhesion. Secondly, we examined
whether mechanical stretch of HMCs induces ICAM-1 via
an MCP-1/CCR2-mediated mechanism.
RESULTS
CCR2 mRNA and protein are expressed in HMCs
HMCs constitutively express the mRNA encoding for the
CCR2 receptor, as determined by reverse transcriptase-
polymerase chain reaction (Figure 1a). A single polymerase
chain reaction (PCR) product of 406 bp was obtained, the
identity of which was confirmed by digestion with the
restriction enzyme AscI yielding two fragments of 174 and
232 bp as predicted from the known cDNA sequence for
CCR2. Amplification of the synthetic double-stranded DNA,
used as positive control, gave a single band of 320 bp, as
expected (Figure 1a).
The presence of CCR2 protein was confirmed by
immunoblotting of total protein extracts, demonstrating a
band migrating at B38 kDa, corresponding to the reported
molecular weight of CCR2.10 The specificity of the band was
confirmed by the absence of signal in the negative control
and by the presence of a band of identical molecular weight
in total protein extracts from THP-1, a monocyte cell line
used as positive control (Figure 1b).
Surface CCR2 protein expression was demonstrated by
flow cytometry using an anti-CCR2 antibody recognizing the
external domain of the CCR2 molecule. Specifically, CCR2
expression was present in approximately 60% of both
primary and immortalized HMCs (Figure 1c).
MCP-1 binding to CCR2 induces ICAM-1 expression in HMCs
To investigate whether mesangial cells, besides expressing
CCR2 at the mRNA and protein levels, display a functional
response to MCP-1, mesangial cells were exposed to
increasing rh-MCP-1 concentrations (0.1, 1, 10, 50, 100 ng/
ml) for various time periods (3, 6, 12, and 24 h) and cell
surface ICAM-1 expression assessed by both indirect
immunofluorescence and cytofluorimetry. Endotoxin con-
tamination of the rh-MCP-1 preparation was excluded by the
Limulus test assay.
Mesangial cell exposure to rh-MCP-1 induced a significant
increase over control in cell surface ICAM-1 protein
expression at 24 h with no changes at earlier time points
(Figure 2a–d). MCP-1 induced ICAM-1 expression in a
concentration-dependent manner with a peak effect at 10 ng/ml
(0.1 ng/ml: 1.5870.05, 1 ng/ml: 1.7370.15, 10 ng/ml:
1.8970.13, 50 ng/ml: 1.7770.05, 100 ng/ml: 1.8570.13
relative fluorescence intensity, fold increase over control,
Po0.01); this concentration was thus used in subsequent
experiments. ICAM-1 induction by MCP-1 was confirmed
in primary HMCs (10 ng/ml: 2.170.11 relative fluore-
scence intensity, fold increase over control, Po0.01) and by
cytofluorimetric analysis (Figure 3). To test whether ICAM-1
induction was a specific effect of MCP-1 occurring via the
CCR2 receptor, experiments were performed in the
presence of a highly specific inhibitor of CCR2 signalling,
RS102895 (RS 6 mM), added 60 min before rh-MCP-1.
This compound, which belongs to the spiropiperidine
family, interacts specifically with the CCR2-binding domain
and has no significant inhibitory activity on other
chemokine receptors.21 The addition of RS completely
abolished MCP-1-induced ICAM-1 expression at 24 h
(MCP-1: 2.1870.38; MCP-1þRS: 0.9370.14; relative
fluorescence intensity Po0.05), confirming that the
effect was specific and mediated via the CCR2 receptor
(Figure 2e–f).
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Figure 1 | CCR2 mRNA and protein are constitutively expressed in
HMCs. Total RNA and protein were extracted from HMCs and
analysed for CCR2 by both reverse transcriptase-polymerase chain
reaction and immunoblotting as described in the Materials and
Methods. (a) Representative 1.5% agarose gel stained with ethidium
bromide. 1: Molecular weight marker F174, Hae III. 2: negative
control. 3 and 4: amplicons from primary and SV40 transformed
HMCs, respectively (406 bp). 5: positive control (320 bp). (b) Cell
lysates were separated by 12% sodium –dodecyl sulphate-polyacry-
lamide gel electrophoresis, transferred on nitrocellulose membranes
and the CCR2 receptor detected by immunoblotting using a goat
polyclonal anti-human CCR2 antibody. A representative immunoblot
is shown and the arrow points to the specific band for CCR2 at
B38 kDa. NC: negative control obtained by omitting the first
antibody. MC: total protein extracts from mesangial cells. PC: total
protein extracts from the monocyte cell line THP-1 used as positive
control. (c) Representative histogram showing surface CCR2 expres-
sion in HMCs (white histogram). Nonspecific staining (grey histogram)
was determined using an irrelevant IgG antibody (IgG1).
Kidney International (2006) 69, 856–863 857
S Giunti et al.: MCP-1 induces ICAM-1 in human mesangial cells o r i g i n a l a r t i c l e
MCP-1-induced ICAM-1 enhances monocyte adhesion
in HMCs
ICAM-1 is a monocyte adhesion molecule and plays a key
role in monocyte–mesangial cell interaction. To establish
whether MCP-1-induced ICAM-1 expression results in
enhanced monocyte adhesion to mesangial cells, we
performed a monocyte adhesion bioassay. Mesangial
cells were exposed to either rh-MCP-1 (10 ng/ml) or vehicle
for 24 h, extensively washed, then co-incubated with
prestained monocytes. The number of monocytes adherent
to mesangial cells pre-exposed to rh-MCP-1 was signifi-
cantly greater than that of monocytes adherent to mesangial
cells exposed to vehicle (MCP-1: 3.670.22, fold increase
over control after 15 h, Po0.05). This was also true at
the earlier time point of 3 h co-incubation (MCP-1:
3.870.18, fold increase over control after 3 h, Po0.05).
The addition of an anti-ICAM-1 antibody (a-ICAM 20mg/ml)
60 min before monocyte co-incubation significantly reduced
the effect (Figure 4), indicating that MCP-1 enhanced
mesangial cell adhesion to monocytes by upregulating
ICAM-1.
Stretch-induced ICAM-1 expression is MCP-1 independent
Mesangial cell exposure to stretch is known to induce both
ICAM-120 and MCP-119 expression. Having established that
exogenous MCP-1 enhances ICAM-1 expression in mesangial
cells via the CCR2 receptor, we tested whether stretch-
induced MCP-1 mediates ICAM-1 upregulation via the same
signalling pathway. Mesangial cell exposure to stretch
induced a significant increase in cell surface ICAM-1 protein
expression at 12 h (4.2370.5, fold increase over control,
Po0.05) with no significant changes at earlier time points
(4 h: 1.2770.8, 6 h: 1.3870.3, fold increase over control,
P¼NS). The addition of RS102895 did not prevent stretch-
induced ICAM-1 expression at 12 h (Figure 5), indicating
that CCR2 signalling is not required for ICAM-1 induction
by stretch. There was a 36% reduction in stretch-induced
ICAM-1 expression in mesangial cells preincubated with the
protein kinase C (PKC) peptide inhibitor PKC19-36;
however, this effect did not reach statistical significance.
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Figure 2 | MCP-1 induces ICAM-1 expression in HMCs. Serum-
deprived mesangial cells were exposed to rh-MCP-1 (10 ng/ml) in the
presence and in the absence of the CCR2 inhibitor RS102895 (RS
6 mM), then stained for ICAM-1 by indirect immunofluorescence as
described in the Materials and Methods. Representative images of
four independent experiments: (a) vehicle, (b) rh-MCP-1 for 3 h,
(c) MCP-1 for 24 h, (d) negative control, (e) RS for 24 h, (f) rh-MCP-
1þ RS for 24 h. Fluorescent intensity was assessed by digital analysis
(Windows MicroImage, version 3.4 CASTI Imaging) on images
obtained using a low-light video camera (Leica DC100). Original
magnification  400.
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Figure 3 | MCP-1 induces surface ICAM-1 expression in HMCs.
Serum-deprived HMCs were exposed to rh-MCP-1 at 10 ng/ml (grey
histogram) or vehicle (empty histogram) for 24 h and cell surface
ICAM-1 expression assessed by flow cytometry for ICAM-1 as
described in the Materials and Methods. Negative control (dotted
histogram) was obtained using an irrelevant IgG antibody (IgG1)
(n¼ 3; Po0.01 MCP-1 vs vehicle).
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Figure 4 | ICAM-1 mediates MCP-1 induced monocyte adhesion to
HMCs. Mesangial cells were exposed to rh-MCP-1 (10 ng/ml) for 24 h,
extensively washed, then co-incubated with human monocytes for
15 h. An anti-ICAM-1 blocking antibody (20 mg/ml) was added 60 min
before co-incubation with monocytes. The number of monocytes
adherent to mesangial cells was counted as described in the
Materials and Methods and expressed as fold increase vs control
(n¼ 3; *Po0.05 MCP-1 vs others).
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Mechanical stretch downregulates CCR2 via
a MCP-1-independent mechanism
Application of mechanical stretch resulted in a significant
reduction in CCR2 mRNA levels at 6 and 12 h with a return
to the baseline by 24 h (Figure 6a). The reduction in CCR2
mRNA levels was followed by a significant decrease in CCR2
protein levels at 12 and 24 h, respectively, with a return to the
baseline by 48 h (Figure 6b).
To test whether MCP-1 is the mediator of stretch-induced
CCR2 downregulation, mesangial cells were exposed to
stretch for 6 h in the presence of either a specific anti-
MCP-1 neutralizing antibody (5 mg/ml) or a control irrele-
vant IgG. Stretch induced a significant decrease in CCR2
mRNA levels that was not altered by the addition of the anti-
MCP-1 antibody (stretch: 41%70.02, stretchþ anti-MCP1
antibody: 46%70.03, percentage reduction, n¼ 3, P¼NS),
indicating that stretch-induced CCR2 downregulation was
MCP-1-independent. Furthermore, mesangial cell exposure
to rh-MCP-1 (100 ng/ml) did not affect CCR2 mRNA
expression (data not shown).
DISCUSSION
In the present study, we have demonstrated that in HMCs
MCP-1 binding to the CCR2 receptor induces monocyte
adhesion via an ICAM-1-dependent mechanism.
Mesangial cell exposure to rh-MCP-1 induced a significant
increase in surface ICAM-1 protein expression at 24 h, as
assessed by both immunofluorescence and flow cytometry.
Besides monocytes, MCP-1 has been shown to be functionally
active in endothelial cells,22 tubular epithelial cells,23 vascular
smooth muscle cells,10 and adipocytes;24 however, this is, to
our knowledge, the first demonstration that MCP-1 has a
direct proinflammatory effect in HMCs. MCP-1 induced
ICAM-1 expression in a concentration-dependent manner
with a minimum effective concentration of 0.1 ng/ml and a
maximal response at 10 ng/ml. These concentrations are
within the higher physiological range, as they are comparable
with those measured both in vitro in mesangial cells exposed
to inflammatory cytokines and in vivo at sites of inflamma-
tion.25 The magnitude of the ICAM-1 response to MCP-1 was
greater when assessed by immunofluorescence. The slightly
lower ICAM-1 induction observed in flow cytometry analysis
may be methodological in nature as analysis of adherent cells
by flow cytometry requires cell detachment, which could
interfere with surface antigen expression.
We confirmed here that expression of both CCR2 mRNA
and protein occurs in HMCs under basal conditions, as
previously reported by others.15,16 Furthermore, ICAM-1
upregulation occurred via the CCR2 receptor as it was
completely abolished by a highly specific inhibitor of CCR2
signalling.21 At variance, in tubular epithelial cells MCP-1-
induced ICAM-1 expression occurs via MCP-1 binding to an
unknown receptor other than CCR2.23
MCP-1-induced ICAM-1 expression was paralleled by an
increase in monocyte adhesion, which was significantly
reduced by the addition of a specific anti-ICAM-1 neutraliz-
ing antibody. This indicates that ICAM-1 upregulation in
response to MCP-1 is functionally relevant as it translates in
enhanced mesangial cell–monocyte adhesion. The physical
interaction between mesangial cells and monocytes is known
to magnify the release of inflammatory cytokines by both cell
types;18,26 therefore, MCP-1 may contribute to the amplifica-
tion of the inflammatory process. Previous studies have
mostly focused on the induction of MCP-1 in mesangial cells
by inflammatory agents.27,28 Our results suggest that,
through the expression of ICAM-1, MCP-1 itself may
function as an important inflammatory mediator in HMCs.
ICAM-1 blockade had little effect on monocyte adhesion to
non-stimulated mesangial cells under basal conditions. This is
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Figure 5 | Stretch-induced ICAM-1 expression is MCP-1-indepen-
dent. Human mesangial cells were exposed to mechanical stretch for
12 h in the presence and in the absence of the CCR2 inhibitor
RS102895 (RS 6 mM), and then stained for ICAM-1 by indirect
immunofluorescence as described in the Materials and Methods.
ICAM-1 relative fluorescent intensity (n¼ 3; *Po0.05 stretch vs
non-stretch) is expressed as fold increase vs control non-stretched
cells in the absence and in the presence of RS102895.
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Figure 6 | Effect of mechanical stretch on CCR2 mRNA and protein
levels. HMCs were exposed to mechanical stretch for the indicated
time periods. (a) CCR2 mRNA (n¼ 3; *Po0.05 stretch at 6 and 12 h vs
non-stretch) and (b) CCR2 protein (n¼ 3; *Po0.05 stretch at 12 and
24 h vs non-stretch) levels are expressed as fold decrease vs control
non-stretched cells (dotted line).
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in agreement with a previous report29 and indicates that
adhesion molecules other than ICAM-1 are important in the
interaction between monocytes and resting mesangial cells.
We have recently reported that mechanical stretch,
mimicking the haemodynamic insult in vivo, induces MCP-
1 expression in HMCs.19 Having established that MCP-1
induces ICAM-1, we tested whether stretch induces ICAM-1
via an MCP-1-mediated mechanism. We found that mesan-
gial cell exposure to stretch for 12 h induced a significant
increase in ICAM-1 expression, as previously reported in rat
mesangial cells.20 However, this was not prevented by CCR2
blockade, indicating that ICAM-1 upregulation was a direct
effect of stretch independent of MCP-1. In mesangial cells,
PKC is an important intracellular mediator of stretch and
high glucose-induced ICAM-1 expression is PKC-depen-
dent.30,31 However, in this work PKC blockade failed to
prevent stretch-induced ICAM-1, indicating that PKC-
independent pathway/s are involved.
Mesangial cells exposure to stretch induced a significant
decrease in CCR2 protein expression at 12–24 h with a return to
the baseline at 48 h. This is unlikely to be due to ligand-
dependent receptor internalization as we also found a reduction
in CCR2 mRNA levels. Furthermore, downregulation of CCR2
gene expression was not prevented by MCP-1 blockade,
excluding a suppressive MCP-1 effect at transcription level.
Therefore, stretch independently induces both MCP-1 upregu-
lation and CCR2 downregulation in HMCs. Reduced MCP-1
responsiveness due to CCR2 downregulation may explain why
MCP-1, though released in response to stretch, does not
contribute to stretch-induced ICAM-1 upregulation. In keeping
with this hypothesis, CCR2 protein levels were diminished at
12 h when ICAM-1 was found to be upregulated.
MCP-1 secretion paralleled by CCR2 downregulation is a
common pattern of response to MCP-1 inducers as
previously reported in mesangial cells exposed to high
glucose15 and in monocytes exposed to TNF-a,32 lipopoly-
saccharides,33 and interferon-g.34 At sites of inflammation
this response by enhancing local MCP-1 availability favours
recruitment of monocytes, which in turn are an important
source of MCP-1,35 thus perpetuating a cycle with pro-
inflammatory potential.
As MCP-1 inducers downregulate CCR2, the direct effect
of MCP-1 on mesangial cell ICAM-1 expression, herein
reported, is unlikely to occur via an autocrine mechanism.
MCP-1 released by either infiltrating monocytes or neigh-
bouring glomerular cells is more likely to be implicated. This
raises the possibility that stretch-induced ICAM-1 expression
in HMCs is biphasic. Initially stretch induces ICAM-1
upregulation and triggers monocyte recruitment, and then
MCP-1, released by infiltrating monocytes, induces ICAM-1
via a paracrine mechanism.
These in vitro findings may have important implications
for in vivo pathophysiological conditions.
Local recruitment of monocytes is considered the
predominant mechanism by which MCP-1 contributes to
glomerular damage in both diabetic and hypertensive
glomerulopathy. Others and we have reported that in
cultured mesangial cells both high glucose15 and stretch19
induce MCP-1 expression, leading to enhance monocyte
chemotaxis.
Monocyte infiltration requires both CCR2 expression on
circulating monocytes to allow monocyte recruitment and
CCR2 downregulation at sites of inflammation. The latter is
aimed to locally retain monocytes as well as to enhance MCP-1
bioavailability, thus favouring further monocyte recruit-
ment.32–34 The importance of local CCR2 expression in
controlling MCP-1 levels through sequestration is confirmed
by the profound increase in tissue MCP-1 levels in CCR2
knockout mice.36 Stretch-induced CCR2 downregulation in
mesangial cells may, thus, represent a mechanism whereby
the haemodynamic insult of glomerular capillary hyperten-
sion favours MCP-1-driven monocyte recruitment.
The physical interaction between monocytes and mesan-
gial cells is a key event in the amplification of the
inflammatory cascade18 and may contribute to glomerular
injury by inducing the release of cytotoxic reactive oxidative
species.37 Our in vitro data showing that MCP-1, through
ICAM-1 upregulation, enhances monocyte–mesangial cell
adhesion provide a novel mechanism whereby MCP-1 can
contribute to glomerular injury.
In conclusion, our data support the view that the MCP-1/
CCR2 system has biological effects that extend beyond
monocyte recruitment.
MATERIALS AND METHODS
Materials
All materials were purchased from Sigma-Aldrich (St Louis, MO,
USA) unless otherwise stated. Flex I and Flex II plates were obtained
from Flexcell International Corporation (McKeensport, PA, USA),
fetal calf serum from Euroclone (Milan, Italy), and Dulbecco’s
modified Eagle’s medium from Invitrogen (Carlsbad, CA, USA).
RNeasy Mini spin columns and TAQ were purchased from Qiagen
(Crawley, UK), the reverse transcription system from Promega
(Madison, WI, USA), and the restriction enzyme AscI from Roche
Diagnostics (Basel, Switzerland). The goat anti-human CCR2
antibody was from Calbiochem (Nottingham, UK), the fluorescein
isothiocyanate-conjugated rabbit anti-mouse antibody from DAKO
(Glostrup, Denmark), the mouse anti-human ICAM-1 and the IgG1
control antibody were from Serotec (Oxford, UK). Oligonucleotide
primers, synthetic double-stranded DNA, rh-MCP-1, anti-MCP-1
neutralizing antibody and the monoclonal anti-CCR2 antibody were
obtained from R&D Systems (Minneapolis, MN, USA). THP-1 total
protein extracts and control IgG1 were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA), Supersignal West Femto
from Pierce (Rockford, IL, USA), Lymphoprep from Nycomed
Pharma AS (Oslo, Norway), and the PKC peptide inhibitor
PKC19-36 from Alexis (Nottingham, UK).
Mesangial cell culture
Cells were isolated and characterized as described previously.38,39
Normal renal cortex was obtained from either donor nephrectomies
found to be unsuitable for transplantation on the basis of an
abnormal vascular supply or taken from the opposite tumour-free
pole of nephrectomy specimens, removed for localized, capsulated
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grade 1 hypernephromas. Tissue was analysed by light microscopy
and by immunofluorescence to confirm the absence of tumour cells
and to exclude the presence of glomerular abnormalities.40
Differentiated immortalized HMCs were obtained by infection of
a pure primary culture with a hybrid Adeno5/SV40 virus.41
Individual foci of immortalized cells were subcultured, and
characterized according to phenotype. A differentiated mesangial
cell line was then selected and used in the study. Cells were cultured
in Dulbecco’s modified Eagle’s medium, containing L-glutamine,
6 mM glucose, 20% heat-inactivated fetal calf serum, 100 U/ml
penicillin, and 100 mg/ml streptomycin in a humidified 5% CO2
incubator at 371C. Studies were performed at passages 20–35 and
cells were serum deprived for 24 h before the experiment. A subset of
experiments was performed in primary HMCs to validate the results
obtained in immortalized mesangial cells.
Semiquantitative reverse transcriptase-polymerase chain
reaction
Total RNA was extracted using RNeasy Mini spin columns and
reverse transcribed (1 mg) according to standard protocols using
avian myeloblastosis virus reverse transcriptase and oligod(T). The
PCR was performed with oligonucleotide primers specifically
designed to amplify human CCR2 (R&D System) and giving a
PCR product of 406 bp. Following an initial denaturation at 941C
for 4 min, the cDNA was amplified for 32 cycles with the following
setting: denaturation at 941C for 45 s, annealing at 551C for 45 s,
elongation at 721C for 45 s with a final elongation at 721C for
10 min. A synthetic double-stranded DNA, whose amplification
gives a 320 bp PCR product, was used as positive control. Expression
of the housekeeping gene glyceraldehyde 3-phosphate dehydrogen-
ase was determined in parallel using primer sequences previously
reported.42 PCR products were resolved in a 1.5% agarose gel
containing ethidium bromide, then analysed and quantified by
Image Analysis Software (Kodak 1D 3.5).
Immunoblotting
Cells were harvested in a Tris (50 mM, pH 7.6) lysis buffer containing
150 mmol/l NaCl, 0.25% deoxycholate, 1% NP40, 10 mmol/l NaF,
2 mmol/l ethyleneglycol tetraacetic acid, 1 mmol/l phenylmethylsul-
phonyl fluoride, 10mg/ml leupeptin, and 10mg/ml aprotinin. Total
protein extracts were separated by 12% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis and electrotransferred to nitro-
cellulose membranes. The membranes were blocked in 5% skimmed
milk in Tris buffer–Tween-20 (pH 7.6) and incubated with a goat
anti-human CCR2 antibody. After washing in Tris buffer–Tween-20,
membranes were incubated with a donkey anti-goat horseradish
peroxidase-linked secondary antibody. Detection was performed by
enhanced chemiluminescence (Supersignal West Femto, Rockford,
IL, USA) and the band intensity quantified by densitometry. Equal
protein loading of each lane was verified with Ponceau S staining of
total proteins on the nitrocellulose membranes. Total protein
extracts from THP-1, a monocyte leukaemia cell line, were used as
positive control.
Immunofluorescence
Mesangial cells were fixed in 3.5% paraformaldehyde containing 2%
sucrose for 30 min at room temperature. After blocking in 3%
bovine serum albumin in phosphate buffered saline (PBS) for
30 min, cells were incubated with a mouse anti-human ICAM-1
antibody (100 mg/ml) for 60 min at 371C. After rinsing, cells were
incubated with a fluorescein isothiocyanate-conjugated rabbit anti-
mouse antibody for 60 min at room temperature. Fluorescent
intensity was assessed on six microscopic fields by digital analysis
(Windows MicroImage, version 3.4 CASTI Imaging) on images
obtained using a low-light video camera (Leica DC100). The
background fluorescence was subtracted by digital image analysis,
the results were corrected for cell density, then expressed as relative
fluorescence intensity on a scale from 0 (fluorescence of back-
ground) to 255 (fluorescence of standard filter).
Flow cytometry analysis
Cells were detached from plates using a non-enzymatic cell
dissociation solution and washed in PBS containing 4% heat-
inactivated human serum. After blocking with whole heat-
inactivated human serum for 15 min, cells were incubated with
either a mouse anti-human ICAM-1 (100 mg/ml) or an IgG1 control
antibody diluted in PBS-4% serum for 15 min at room temperature,
and with either a mouse anti-human CCR2 or an IgG1 control
antibody diluted in PBS-4% serum for 45 min at 41C. After washing,
cells were incubated with a fluorescein isothiocyanate-conjugated
rabbit anti-mouse antibody. Cells were washed twice with PBS-4%
serum, then analysed by flow cytometry (FACscan, Becton-
Dickinson, Mountainview, CA, USA). For each determination
10 000 cells were analysed.
Adhesion bioassay
Monocytes were isolated from total blood samples of human healthy
volunteers using Lymphoprep density gradient centrifugation
followed by adhesion separation in Dulbecco’s modified Eagle’s
medium containing 10% fetal calf serum. Freshly isolated mono-
cytes were stained with green fluorescent PKH2 dye, and then co-
incubated with mesangial cells for 15 h in serum-free medium.
Shorter-term 3 h co-incubation experiments were also conducted.
Non-adherent cells were removed by extensive washing and the
number of monocytes adherent to mesangial cells counted and
expressed as number of adherent cells/100 HMCs.43 Each experi-
ment was carried out in triplicate and at least five high-power fields
were counted per well.
Application of mechanical stretch to cultured cells
Mesangial cells were seeded in equal number (12 000/cm2) into six-
well type I collagen-coated silicon elastomer-base culture plates
(Flex I plates) and control plates (Flex II plates). After serum
deprivation for 24 h, cells were subjected to repeated stretch/
relaxation cycles by mechanical deformation using a Stress Unit. The
Stress Unit is a modification of the unit initially described by Banes
et al.44 and consists of a vacuum unit and a baseplate. A vacuum was
cyclically applied (60 cycles/min) to the rubber-base plates via the
baseplate, which was placed in a humidified incubator with 5% CO2
at 371C. Cells were exposed to an average 10% uniaxial elongation,
which mimics that present in vivo in glomeruli exposed to
supernormal pressure levels,45 and is known to induce both MCP-1
and cytokine production in cultured mesangial cells.19,39 Stretch and
control experiments were carried out simultaneously with cells
derived from a single pool. Control cells were grown in non-
deformable, but otherwise identical plates in parallel.
Data presentation and statistical analysis
The number of independent experiments is reported in the legends
to figure. Each experiment was carried out in triplicate. All data are
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presented as mean7s.e.m. Data are expressed as fold change over
control. Student’s t-test was used for the comparison between two
groups. When more than two groups were studied, data were
analysed by ANOVA and if significant, the Newman–Keuls was used
for post hoc comparisons. Values for Po0.05 were considered
significant.
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